Alteration of the p53 pathway has been reported to be systematically observed in non-small cell lung cancer with activating EGFR mutations, suggesting that p53 inactivation is required to allow expansion of a cell with EGFR pathway activation (Mounawar et al, 2007). Here, TP53 is linked to non-small cell lung carcinoma.